| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $178.70M | $142.26M | $104.96M | $106.99M | $71.49M |
| R&D | $157.70M | $124.52M | $86.14M | $82.27M | $51.10M |
| SG&A | $21.00M | $17.74M | $18.82M | $24.71M | $20.39M |
| Operating Income | -$178.70M | -$142.26M | -$104.96M | -$106.99M | -$71.49M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $3.00K | $2.00K | $2.00K | $1.00K | – |
| Net Income | -$162.45M | -$129.47M | -$96.66M | -$104.79M | -$71.10M |
| EPS (basic) | -1.8700 | -2.2000 | -2.1400 | -2.6200 | -1.8000 |
| EPS (diluted) | -1.8700 | -2.2000 | -2.1400 | -2.6200 | -1.8000 |
| Shares (diluted) | $87.01M | $58.74M | $45.25M | $40.00M | $39.52M |